blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4155293

EP4155293 - PRC1 INHIBITORS AND METHODS OF TREATMENT THEREWITH [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  08.12.2023
Database last updated on 03.10.2024
FormerRequest for examination was made
Status updated on  06.10.2023
FormerThe application has been published
Status updated on  24.02.2023
Most recent event   Tooltip24.09.2024New entry: Despatch of examination report + time limit 
Applicant(s)For all designated states
The Regents of The University of Michigan
1600 Huron Parkway, 2nd Floor
Ann Arbor, Michigan 48109-2590 / US
[2023/13]
Inventor(s)01 / CIERPICKI, Tomasz
Ann Arbor, 48109 / US
02 / GREMBECKA, Jolanta
Ann Arbor, 48109 / US
03 / YING, Weijiang
Ann Arbor, 48109 / US
04 / YAO, Yiwu
Ann Arbor, 48109 / US
05 / GRAY, Felicia
Ann Arbor, 48109 / US
06 / ZHAO, Qingjie
Ann Arbor, 48109 / US
 [2023/13]
Representative(s)Glawe, Delfs, Moll
Partnerschaft mbB von
Patent- und Rechtsanwälten
Postfach 13 03 91
20103 Hamburg / DE
[2023/13]
Application number, filing date22205619.407.06.2019
[2023/13]
Priority number, dateUS201862681989P07.06.2018         Original published format: US 201862681989 P
[2023/13]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP4155293
Date:29.03.2023
Language:EN
[2023/13]
Search report(s)(Supplementary) European search report - dispatched on:EP07.02.2023
ClassificationIPC:C07D207/32, C07D207/333, C07D207/337, C07D403/14, A61K8/49, A61K31/215, A61K31/216, C07D405/14, C07D471/04, A61P35/00
[2023/13]
CPC:
A61P35/00 (EP); C07D403/14 (EP,US); A61K31/404 (EP);
A61K31/4184 (EP); A61K31/422 (EP); A61K31/427 (EP);
A61K31/428 (EP); A61K31/437 (EP); A61K31/4439 (EP);
A61K45/06 (EP,US); C07D207/34 (EP); C07D333/40 (EP);
C07D401/14 (EP); C07D403/04 (EP,US); C07D405/14 (EP,US);
C07D413/14 (EP,US); C07D417/14 (EP,US); C07D471/04 (EP,US);
C07D471/16 (EP,US); C07D493/10 (EP,US); C07D498/06 (EP,US);
C07D498/16 (US); C07D513/16 (EP,US); A61K9/0019 (US);
A61K9/0053 (US) (-)
C-Set:
A61K31/404, A61K2300/00 (EP);
A61K31/4184, A61K2300/00 (EP);
A61K31/422, A61K2300/00 (EP);
A61K31/427, A61K2300/00 (EP);
A61K31/428, A61K2300/00 (EP);
A61K31/437, A61K2300/00 (EP);
A61K31/4439, A61K2300/00 (EP)
(-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/45]
Former [2023/13]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:PRC1-INHIBITOREN UND VERFAHREN ZUR BEHANDLUNG DAMIT[2023/13]
English:PRC1 INHIBITORS AND METHODS OF TREATMENT THEREWITH[2023/13]
French:INHIBITEURS DE PRC1 ET MÉTHODES DE TRAITEMENT COMPRENANT CES DERNIERS[2023/13]
Examination procedure29.09.2023Amendment by applicant (claims and/or description)
29.09.2023Examination requested  [2023/45]
29.09.2023Date on which the examining division has become responsible
12.12.2023Despatch of a communication from the examining division (Time limit: M04)
07.03.2024Reply to a communication from the examining division
27.05.2024Despatch of a communication from the examining division (Time limit: M02)
17.07.2024Reply to a communication from the examining division
23.09.2024Despatch of a communication from the examining division (Time limit: M04)
Parent application(s)   TooltipEP19815644.0  / EP3813784
Fees paidRenewal fee
04.11.2022Renewal fee patent year 03
04.11.2022Renewal fee patent year 04
22.06.2023Renewal fee patent year 05
21.06.2024Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO2015030847  (PTC THERAPEUTICS INC [US]);
by applicantUS510
 US949
 US5863
 US5861
 US3598122
 US3598123
 US3710795
 US3731683
 US3742951
 US3814097
 US3921636
 US3972995
 US3993072
 US3993073
 US3996934
 US4031894
 US4060084
 US4069307
 US4077407
 US4151273
 US4201211
 US4229447
 US4230105
 US4292299
 US4292303
 US4343789
 US4476116
 US4596795
 US4755386
 WO9005719
 US5033252
 US5052558
 US5116817
 US5281420
 US5323907
 EP0606046
 US5336168
 US5340591
 US5456923
 WO9627583
 WO9633172
 EP0780386
 US5665378
 US5700485
 WO9801113
 WO9803516
 WO9807697
 US5723269
 US5739136
 WO9830566
 WO9833768
 WO9834918
 WO9834915
 US5837280
 US5858401
 US5869090
 WO9929667
 EP0931788
 WO9952910
 WO9952889
 US6083518
 US6391452
 US6667048
 US2004013734
 US6923983
 US6929801
 US6946144
 US6960563
 US19640601484
 EP19970304971
 EP19990302232
 GB19990012961
 EP19990308617
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.